Cresco Labs Stock Performance
| CRLBF Stock | USD 1.05 0.01 0.96% |
On a scale of 0 to 100, Cresco Labs holds a performance score of 4. The firm shows a Beta (market volatility) of 0.0471, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cresco Labs' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cresco Labs is expected to be smaller as well. Please check Cresco Labs' treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to make a quick decision on whether Cresco Labs' price patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Cresco Labs are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental drivers, Cresco Labs reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 140.8 M | |
| Total Cashflows From Investing Activities | -163.9 M |
Cresco |
Cresco Labs Relative Risk vs. Return Landscape
If you would invest 108.00 in Cresco Labs on November 5, 2025 and sell it today you would lose (3.00) from holding Cresco Labs or give up 2.78% of portfolio value over 90 days. Cresco Labs is currently producing 0.7568% returns and takes up 14.1136% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Cresco, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Cresco Labs Target Price Odds to finish over Current Price
The tendency of Cresco OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.05 | 90 days | 1.05 | about 59.87 |
Based on a normal probability distribution, the odds of Cresco Labs to move above the current price in 90 days from now is about 59.87 (This Cresco Labs probability density function shows the probability of Cresco OTC Stock to fall within a particular range of prices over 90 days) .
Cresco Labs Price Density |
| Price |
Predictive Modules for Cresco Labs
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cresco Labs. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cresco Labs Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cresco Labs is not an exception. The market had few large corrections towards the Cresco Labs' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cresco Labs, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cresco Labs within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.53 | |
β | Beta against Dow Jones | 0.05 | |
σ | Overall volatility | 0.24 | |
Ir | Information ratio | 0.04 |
Cresco Labs Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cresco Labs for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cresco Labs can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cresco Labs is way too risky over 90 days horizon | |
| Cresco Labs has some characteristics of a very speculative penny stock | |
| Cresco Labs appears to be risky and price may revert if volatility continues | |
| Cresco Labs has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 821.68 M. Net Loss for the year was (319.6 M) with profit before overhead, payroll, taxes, and interest of 429.79 M. | |
| About 23.0% of the company shares are held by company insiders |
Cresco Labs Fundamentals Growth
Cresco OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Cresco Labs, and Cresco Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cresco OTC Stock performance.
| Return On Equity | -0.0635 | |||
| Return On Asset | 0.0399 | |||
| Profit Margin | (0.08) % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 1.29 B | |||
| Shares Outstanding | 280.99 M | |||
| Price To Book | 0.95 X | |||
| Price To Sales | 0.83 X | |||
| Revenue | 821.68 M | |||
| EBITDA | (159.63 M) | |||
| Cash And Equivalents | 130.04 M | |||
| Cash Per Share | 0.43 X | |||
| Total Debt | 465.08 M | |||
| Debt To Equity | 0.88 % | |||
| Book Value Per Share | 2.62 X | |||
| Cash Flow From Operations | 14.49 M | |||
| Earnings Per Share | (1.15) X | |||
| Total Asset | 1.78 B | |||
About Cresco Labs Performance
By analyzing Cresco Labs' fundamental ratios, stakeholders can gain valuable insights into Cresco Labs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cresco Labs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cresco Labs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. The company was founded in 2013 and is headquartered in Chicago, Illinois. Cresco Labs operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3300 people.Things to note about Cresco Labs performance evaluation
Checking the ongoing alerts about Cresco Labs for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Cresco Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cresco Labs is way too risky over 90 days horizon | |
| Cresco Labs has some characteristics of a very speculative penny stock | |
| Cresco Labs appears to be risky and price may revert if volatility continues | |
| Cresco Labs has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 821.68 M. Net Loss for the year was (319.6 M) with profit before overhead, payroll, taxes, and interest of 429.79 M. | |
| About 23.0% of the company shares are held by company insiders |
- Analyzing Cresco Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cresco Labs' stock is overvalued or undervalued compared to its peers.
- Examining Cresco Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cresco Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cresco Labs' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Cresco Labs' otc stock. These opinions can provide insight into Cresco Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cresco OTC Stock analysis
When running Cresco Labs' price analysis, check to measure Cresco Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cresco Labs is operating at the current time. Most of Cresco Labs' value examination focuses on studying past and present price action to predict the probability of Cresco Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cresco Labs' price. Additionally, you may evaluate how the addition of Cresco Labs to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |